How elderberry and gut bacteria may help fight viruses
Contributions of host and gut microbial mediated metabolism to the antiviral activity of elderberry
This study is looking at how elderberry, a popular herbal supplement, works in the body to see if it can help fight viruses like COVID-19, so people can learn how to use it better for their health.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10914288 on NIH RePORTER |
What this research studies
This research investigates the antiviral properties of elderberry, a popular herbal supplement, by examining how it is metabolized by the body and gut microbiome. The study aims to identify the active compounds and their effectiveness against viruses, particularly in the context of COVID-19. By understanding the metabolic processes that enhance the bioavailability of elderberry's beneficial components, the research seeks to provide insights into its potential therapeutic effects. Patients may benefit from a better understanding of how elderberry can be used effectively as a dietary supplement for viral infections.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals interested in herbal supplements, particularly those seeking alternative treatments for viral infections.
Not a fit: Patients who do not use herbal supplements or are not interested in alternative medicine may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved antiviral treatments using elderberry, enhancing patient outcomes during viral infections.
How similar studies have performed: While there is growing interest in the antiviral properties of herbal supplements, this specific approach to studying elderberry's metabolism and efficacy is relatively novel and has not been extensively tested.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Crandall, William Joseph — Emory University
- Study coordinator: Crandall, William Joseph
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.